Welcome to Nutraceuticals World   
July/August 2014 Issue
Last Updated Friday, August 22 2014
Print

Unigen Pharmaceuticals, Inc.



Published July 1, 2005
Unigen Pharmaceuticals, Inc., Lacey, WA, has been issued a composition of matter and usage patent for the company’s proprietary antioxidant ingredients contained in its Aloewhite and Pervarin commercial raw material ingredient products from the U.S. Patent and Trademark Office. Through the identification and purification of specific aloe chromones derived from aloe vera and other plant species, Unigen scientists have demonstrated the effectiveness of these chromones in inhibiting free radical and oxidative damage through the simultaneous suppression of free radical generation and production of Reactive Oxygen Species (ROS), which includes oxygen-related free radicals.


Receive free Nutraceuticals World emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Nutraceuticals World On